Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns

被引:67
作者
Saurina, G
Quale, JM
Manikal, VM
Oydna, E
Landman, D
机构
[1] SUNY Hlth Sci Ctr, Dept Med, Div Infect Dis, Brooklyn, NY 11203 USA
[2] Dept Vet Affairs Med Ctr, Dept Microbiol, Brooklyn, NY USA
关键词
D O I
10.1093/jac/45.6.895
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In November 1997, all Enterobacteriaceae isolated at 15 hospitals in Brooklyn were collected. Extended-spectrum beta-lactamases (ESBLs) were present in 44% of 409 Klebsiella pneumoniae isolates. Six isolates had reduced susceptibility to carbapenems, including two that were not susceptible to any of the antibiotics tested. Pulsed field gel electrophoresis revealed a commonality of resistant isolates within and between hospitals. The occurrence of ESBL-containing Isolates was associated with cephalosporin usage (P = 0.055). ESBLs were present in 4.7% of Escherichia coli and 9.5% of Proteus mirabilis isolates, It is concluded that ESBL-producing Enterobacteriaceae are endemic in Brooklyn, are spread between hospitals, and may be associated with cephalosporin usage.
引用
收藏
页码:895 / 898
页数:4
相关论文
共 8 条
[1]   LABORATORY INVESTIGATION OF A MULTISTATE FOOD-BORNE OUTBREAK OF ESCHERICHIA-COLI O157-H7 BY USING PULSED-FIELD GEL-ELECTROPHORESIS AND PHAGE TYPING [J].
BARRETT, TJ ;
LIOR, H ;
GREEN, JH ;
KHAKHRIA, R ;
WELLS, JG ;
BELL, BP ;
GREENE, KD ;
LEWIS, J ;
GRIFFIN, PM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (12) :3013-3017
[2]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[3]  
Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522
[4]   Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs:: A 1997 surveillance trial in 102 medical centers in the United States [J].
Jones, RN ;
Pfaller, MA ;
Doern, GV ;
Erwin, ME ;
Hollis, RJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (03) :215-228
[5]   Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary [J].
Landman, D ;
Chockalingam, M ;
Quale, JM .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1062-1066
[6]  
Monnet DL, 1997, INFECT CONT HOSP EP, V18, P492
[7]  
*NAT COMM CLIN LAB, 1998, M100S8 NCCLS
[8]   Glass restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella [J].
Rahal, JJ ;
Urban, C ;
Horn, D ;
Freeman, K ;
Segal-Maurer, S ;
Maurer, J ;
Mariano, N ;
Marks, S ;
Burns, JM ;
Dominick, D ;
Lim, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14) :1233-1237